Today, Kim Bolton and Stockchase Insights commented about whether LNTH-Q, ACHR-N, GLBE-Q, ADBE-Q, RBLX-N, SPOT-N, TSLA-Q, MRVL-Q, CRWV-Q, CRM-N, AMD-Q, SHOP-T, ON-Q, MCHP-Q, IFNNY-OTC, QQQ-Q, MU-Q, MSFT-Q, QUBT-Q, V-N, DCBO-T are stocks to buy or sell.
Most customers are under 18. User growth is accelerating, up 25% YOY. They are big in the US, sort of in Europe, but are expanding in south-east Asia, namely Indonesia. They have commerce API integration in the early stage of advertising that they will put on their platform. They have 600 million monthly users. Are generating lots of cash, but also spending that. They have a net lost. A great business that's growing over 30% in revenues and bookings. Their expect their community to generate $1 billion in creator earnings this year.
(Analysts’ price target is $81.08)Stock momentum has been very weak this year, but if one believes management (and analysts) then things should start to improve. Based on consensus estimates, EPS is expected to more than double in 2026. The company has $400M net cash and growing cash flow ($151M over 12 months). Margins have improve over the past three years. It did beat estimates last quarter. Sales rose 30%. Tariffs still are a question mark overall, but we think priced into the stock now. It could move on any good news, we think.
Unlock Premium - Try 5i Free
ACHR is pre-revenue, but it does have a working product and has completed over 400 test flights in the past year. It has received a few defense certifications, and its exclusive partnership with Anduril focuses on building a next-gen hybrid-electric VTOL aircraft for US defense applications. We like its momentum, it is certainly building interesting applications, but it is pre-revenue and we would consider it to be fairly speculative at this time. For a speculative position, we would be OK here, while acknowledging its small-cap risks, pre-revenue, and position sizing.
Unlock Premium - Try 5i Free
There has been no material news since our last comment. A couple of lawsuits related to the stock's decline but these are common when a stock drops. The company has presented at a couple of investment conferences but nothing new was revealed. The Life Molecular acquisition has not yet closed but closing was not expected yet. It is very cheap at 11X earnings and technicals show a bit oversold. This week there was disclosure of an insider sale of about $400K. Bloomberg shows 13 analysts, 12 BUY 1 HOLD, target $128.42. It looks attractive IF it does not have to guide lower, again. But it may look better once the acquisition has closed and growth is set to accelerate.
Unlock Premium - Try 5i Free
A.I. Investment Themes: Personalized investment advice
AI enables a new level of personalization in investment advice, going beyond standard risk questionnaires. By analyzing an investor’s full financial picture, including spending habits, career trajectory, geographic location and even life events, AI can deliver highly individualized recommendations. These systems adapt over time, continuously learning from investor behaviour to refine advice and keep portfolios aligned with personal circumstances and preferences. This AI benefit should be quite helpful. To advisers, it simply speeds up what they are doing already, under Know Your Client rules. But it will encompass a larger set of circumstances and will allow more continuous updating. This should reduce complaints, free up adviser time and allow clients to have a portfolio that better matches their circumstances, even when these are changing rapidly.
Unlock Premium - Try 5i Free
Is not an investment, but a trade. Look at its volatility. At $350, write some calls. He targets $410. He constantly trims his holding. Is great to buy under $300, and sell above $350. It deserves it premium among car companies. Their future lies in robotics, not EVs. Musk plans to sell robots in 2026.